IRREVERSIBLE ELECTROPORATION TO TREAT PROSTATE CANCER (NANOKNIFE)


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Modern medicine tends to use minimally invasive treatments. Selected patients with prostate cancer may be treated using irreversible electroporation that involves the application of a NanoKnife device. The procedure directs short electrical pulses that open microscopic pores in the cells in the treatment area and effectively destroy cancer cells. This literature review outlines the history of irreversible electroporation, its use in surgery for treating cancers of the pancreas, liver, lung, kidney and brain. This technique is relatively new and is not yet applied in routine urologic practice, but has been increasingly used in Europe and North America and, no doubt, will find an appropriate utilization in Russia.

全文:

受限制的访问

作者简介

P. Glybochko

I.M. Sechenov First Moscow State Medical University

Email: rektorat@mma.ru
Moscow

Yu. Alyaev

I.M. Sechenov First Moscow State Medical University

Moscow

A. Amosov

I.M. Sechenov First Moscow State Medical University

Email: amosov-av@yandex.ru
Moscow

D. Enikeev

I.M. Sechenov First Moscow State Medical University

Email: enikeev_dv@mail.ru
Moscow

D. Chinenov

I.M. Sechenov First Moscow State Medical University

Email: chinenov_dv@mail.ru
Moscow

G. Krupinov

I.M. Sechenov First Moscow State Medical University

Email: gekrupinov@mail.ru
Moscow

Ya. Chernov

I.M. Sechenov First Moscow State Medical University

Email: yarik.chernov@mail.ru
Moscow

A. Tivtikyan

I.M. Sechenov First Moscow State Medical University

Email: aleksandertivtikyan@yandex.ru
Moscow

参考

  1. Максимова Т.М., Белов В.Б. Заболеваемость злокачественными новообразованиями и смертность от них в России и некоторых зарубежных странах. Проблемы социальной гигиены, здравоохранения и истории медицины. 2012;1:9-12
  2. Chevallier D., Amiel J. The treatments of localized prostate cancer: the impact on sexuality. Ann. Urol. (Paris). 2006;40(2)53-56.
  3. van Tol-Geerdink J.J., Leer J.W., van Oort I.M., van Lin E.J., Weijerman P.C., Vergunst H., Witjes J.A., Stalmeier P.F. Quality of life after prostate cancer treatments in patients comparable at baseline. Br. J. Cancer. 2013;108(9):1784-1789.
  4. Wendler J.J., Ganzer R., Hadaschik B., Blana A., Henkel T., Köhrmann K.U., Machtens S., Roosen A., Salomon G., Sentker L., Witzsch U., Schlemmer H.P., Baumunk D., Köllermann J., Schostak M., Liehr U.B. Working Group for Focal and Microtherapy, Academy of the German Society of Urology. [Irreversible electroporation : Current value for focal treatment of prostate cancer]. Urologe. A. 2015;54(6):854-862.
  5. Bos W., Bruin D., Muller B., Varkarakis I., Karagiannis A., Zondervan P., Laguna Pes M., Veelo D., Savci Heijink C., Engelbrecht M., Wijkstra H., Reijke T., Rosette H. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open. 2014;4(10)e006382.
  6. Rubinsky B. Irreversible Electroporation. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010.
  7. Benov L.C., Antonov P.A., Ribarov S.R. Oxidative Damage of the Membrane Lipids after Electroporation. Gen. Physiol. Biophys. 1994;13:85-97.
  8. Mir L.M., Orlowski S., Belehradek J. Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 1991;27(1):68-72.
  9. Wang P.L., Hu L.N., Yang X.J., Li J., Sun C.X., Xiong L., Yao C.G., Wang S.B. Pathological studies of tissue damage in experimental rabbit liver cancer induced by energy controllable steep pulses. Zhonghua Gan Zang Bing Za Zhi. 2005;13(7):516-519.
  10. Jourabchi N., Beroukhim K., Bashir A., Tafti B., Kee S, Lee E., Irreversible electroporation (NanoKnife) in cancer treatment. Gastrointest. Interv. 2014;3:8-18.
  11. Тургунова Н.Д., Мартемьянова Н.И. Исследование возможностей электропорации для лечения злокачественных опухолей. Известия Высших Учебных Заведений. Физика. 2013;56(4-2):309-311
  12. Li D., Kang J., Golas B.J., Yeung V.W., Madoff D.C. Minimally invasive local therapies for liver cancer. Cancer Biol. Med. 2014;11(4):217-236.
  13. Yeung E.S., Chung M.W., Wong K., Wong C.Y., So E.C., Chan A.C. An update on irreversible electroporation of liver tumours. Hong Kong Med. J. 2014;20(4):313-316.
  14. Cannon R., Ellis S., Hayes D., Narayanan G., Martin R.C. 2nd Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J. Surg. Oncol. 2013;107(5):544-549.
  15. Martin R.C. 2nd, McFarland K., Ellis S., Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann. Surg. Oncol. 2013;20(3):443-449.
  16. NCT01939665. PANFIRE - Pilot-study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma [Электронный ресурс]. URL: https://clinicaltrials.gov/ct2/show/ NCT01939665
  17. Панченков Д.Ю., Иванов Ю.В., Пикунов Д.Ю. Необратимая электропорация метастазов колоректального рака в печень с использованием системы «NANOKNIFE» Клиническая практика. 2013;1(13)37-43
  18. icke J., Jürgens J.H., Deschamps F., Tselikas L., Uhde K., Kosiek O., De Baere T. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc. Intervent. Radiol. 2015;38(2):401-408.
  19. Neal R.E. 2nd, Rossmeisl J.H. Jr, D’Alfonso V., Robertson J.L., Garcia P.A., Elankumaran S., Davalos R.V. In vitro and numerical support for combinatorial irreversible electroporation and electrochemotherapy glioma treatment. Ann. Biomed. Eng. 2014;42(3):475-487.
  20. Mandel Y., Laufer S., Belkin M., Rubinsky B., Pe’er J., Frenkel S. Irreversible electroporation of human primary uveal melanoma in enucleated eyes. PLoS One. 2013;8(9).
  21. Панченков Д.Ю. и др. Необратимая электропорация с использованием системы «NanoKnife» в лечении рака поджелудочной железы (клиническое наблюдение) . 2014;19(1):50-54
  22. Pech M., Janitzky A., Wendler J.J., Strang C., Blaschke S., Dudeck O., Ricke J., Liehr U.B. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc. Intervent. Radiol. 2011;34(1):132-138.
  23. Wendler J.J., Porsch M., Nitschke S., Köllermann J, Siedentopf S., Pech M., Fischbach F., Ricke J., Schostak M., Liehr U.B. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp. Clin. Trials. 2015;43:10-19.
  24. Sugimoto K., Moriyasu F., Takeuchi H., Ando M., Sano T., Mori T., Furuichi Y., Kobayashi Y., Nakamura I. Case study to assess the safety of irreversible electroporation near the heart. Springerplus. 2015;4:74.
  25. Cheng R.G., Bhattacharya R., Yeh M.M., Padia S.A. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis. J. Vasc. Interv. Radiol. 2015;26(8):1184-1188.
  26. Philips P., Hays D., Martin R.C.G. Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One. 2013;8(11)e76260.
  27. Ball C., Thomson K.R., Kavnoudias H. Irreversible Electroporation. Anesth. Analg. 2010;110(5):1305-1309.
  28. Mali B., Gorjup V., Edhemovic I., Brecelj E., Cemazar M., Sersa G., Strazisar B., Miklavcic D., Jarm T. The effect of electroporation pulses on functioning of the heart. Med. Biol. Eng. Comput. 2008;46(8):745-757.
  29. Onik G., Mikus P., Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol. Cancer Res. Treat. 2007;6(4):295-300.
  30. NCT01835977. Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer [Электронный ресурс]. URL: https://clinicaltrials.gov/ct2/show/ NCT01835977.
  31. Murray K.S., Ehdaie B., Musser J., Mashni J., Srimathveeravalli G., Durack J.C., Solomon S.B., Coleman J.A. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. J Urol. 2016; S0022-5347(16)30278-6.
  32. Valerio M., Dickinson L., Ali A., Ramachandran N., Donaldson I., Freeman A., Ahmed H.U., Emberton M. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp. Clin. Trials. 2014;39(1):57-65.
  33. Valerio M., Stricker P.D., Ahmed H.U., Dickinson L., Ponsky L., Shnier R., Allen C., Emberton M. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2014;17(4):343-347.
  34. van den Bos W., Jurhill R.R., de Bruin D.M., Savci-Heijink C.D., Postema A.W., Wagstaff P.G., Muller B.G., Varkarakis I.M., Skolarikos A., Zondervan P.J., Laguna Pes M.P., de Reijke T.M., de la Rosette J.J. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study. J Urol. 2016;196(2):552-559.
  35. Valerio M., Cerantola Y., Eggener S.E., Lepor H., Polascik T.J., Villers A., Emberton M. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Eur Urol. 2016:S0302-2838(16)30512-7.
  36. Murray K.S., Ehdaie B., Musser J., Mashni J., Srimathveeravalli G., Durack J.C., Solomon S.B., Coleman J.A. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. J Urol. 2016;S0022-5347(16)30278-6.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2016
##common.cookie##